Search

Your search keyword '"Sinagra G"' showing total 23 results
Start Over Author "Sinagra G" Publication Type Books
23 results on '"Sinagra G"'

2. Myocarditis in Heart Failure

Author

Sinagra, G., primary, Artico, J., additional, Gentile, P., additional, Fabris, E., additional, Bussani, R., additional, Cannatà, A., additional, and Merlo, M., additional

Published
2018
Full Text
View/download PDF

16. Complex Ventricular Arrhythmias in Dilated Cardiomyopathy: A Multicenter Italian Experience

Author

Gavazzi, A., primary, De Maria, R., additional, Caroli, A., additional, Di Lenarda, A., additional, Veritti, U., additional, Miani, D., additional, Sinagra, G., additional, Luvini, M., additional, Ometto, R., additional, Borgia, M., additional, Ciaccheri, M., additional, Campana, C., additional, Graziano, G., additional, Lanzarini, L., additional, Gronda, E., additional, and Camerini, F., additional

Published
1990
Full Text
View/download PDF

18. Immunosuppressive Treatment in Myocarditis

Author

Camerini, F., primary, Salvi, A., additional, Bussani, R., additional, Dreas, L., additional, Di Lenarda, A., additional, Hrovatin, E., additional, Sinagra, G., additional, and Silvestri, F., additional

Published
1988
Full Text
View/download PDF

20. Recent Advances in the Natural History of Dilated Cardiomyopathy: A Review of the Heart Muscle Disease Registry of Trieste.

Author

Atlee, John L., Gullo, Antonino, Sinagra, Gianfranco, Vincent, Jean-Louis, Moretti, M., Lenarda, A., and Sinagra, G.

Abstract

Dilated cardiomyopathy (DCM) is heart muscle disease characterized by left ventricular or biventricular dilatation and impaired myocardial contractility [1]. It is an important cause of morbidity and mortality, and is one of the two most frequent indications for cardiac transplantation. The prevalence of DCM in the United States has been estimated at around 0.04% [2], with an annual incidence of 0.005-0.006% [2, 3]. [ABSTRACT FROM AUTHOR]

Published
2007
Full Text
View/download PDF

21. Heart Failure, Atrial Fibrillation, and Diabetes Mellitus.

Author

Atlee, John L., Gullo, Antonino, Sinagra, Gianfranco, Vincent, Jean-Louis, Aleksova, A., Perkan, A., and Sinagra, G.

Abstract

Diabetes mellitus is a common disease. The worldwide prevalence of diabetes- especially of the predominant type 2 diabetes mellitus which accounts for about 90% of the adult diabetic population-has increased rapidly and continuously during the last several decades. This phenomenon is a direct consequence of negative lifestyle changes in the population, including a reduction of physical activity and the availability of energydense food rich in saturated fat, leading to an increased prevalence of obesity. The global prevalence of diabetes mellitus in adults is predicted to increase to 5.4% in the year 2025 [1]. [ABSTRACT FROM AUTHOR]

Published
2007
Full Text
View/download PDF

22. Sudden Death in Heart Failure: Risk Stratification and Treatment Strategies.

Author

Atlee, John L., Gullo, Antonino, Sinagra, Gianfranco, Vincent, Jean-Louis, Zecchin, M., Vitrella, G., and Sinagra, G.

Abstract

Attempting a careful evaluation of the incidence of sudden death (SD) in congestive heart failure is inevitably a complex and imprecise task. In particular, this is due to the difficulties in defining and understanding the baseline mechanisms underlying SD. "Sudden" death is commonly regarded as a synonym of "cardiac arrest due to ventricular fibrillation," which is in turn considered to be a merely arrhythmic phenomenon occurring during apparent wellbeing, and without any precipitating cause other than an extrasystole or a sustained ventricular tachycardia. Cardiac arrest may also be the terminal event during refractory pulmonary edema and/or cardiogenic shock in a patient with end-stage heart failure, a pulmonary embolism in a patient with severe biventricular dysfunction, bradyarrhythmia due to advanced atrioventricular (AV) block, electrical asystole, ventricular fibrillation secondary to myocardial ischemia or infarction, or secondary to a noncardiac event such as a cerebro vascular accident or a ruptured aortic aneurysm. Pratt et al.[1] analyzed a population of 834 patients with an automatic implantable cardioverter defibrillator (ICD) implanted for ventricular tachycardia or sustained ventricular tachycardia. During follow-up 109 patients died (17 died "suddenly"). Autopsy findings revealed a nonarrhythmic cause (pulmonary embolism, ruptured aortic aneurysm, stroke, acute myocardial infarction) in 7/17 patients. Postmortem analysis of the ICD memory revealed ventricular tachyarrhythmias preceding death in only 7/17 patients. [ABSTRACT FROM AUTHOR]

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results